31-05-2015, 12:45 PM
(This post was last modified: 01-06-2015, 12:23 PM by buyhighselllow.)
(30-05-2015, 02:37 AM)Nick Wrote:(29-05-2015, 04:57 PM)buyhighselllow Wrote:(27-05-2015, 01:47 PM)Nick Wrote: This reminds me of the Talkmed listing which has done really well since its IPO.
Nick, Agree that there are parallels with Talkmed. Same IPO banker too Hong Leong Finance. Both operate in a niche area with a small but growing chain of clinics. We are essentially betting on a few doctors (i.e. Dr Ang Peng Tiam for Talkmed and Dr Lee Keen Whye, Dr Heng Tung Lan, Dr Beh Suan Tiong for SOG) as they are the rainmakers.
I think the main difference is Talkmed Dr Ang is the controlling shareholder, CEO and the main rainmaker. SOG CEO and co-founder Dr Ng Koon Keng does not run his own clinic and owns less than 4%. Not sure whether this is a good or bad thing, curious what forumers think. Good - he can focus on expanding the business as not bogged down serving patients daily. Not good - less alignment of interests if we want to compare with Talkmed since he owns only a small stake
I think it seems like a decent short-medium term investment as the proposed dividend will support the price. Clean balance sheet is obviously a key selling point too. Longer term i'm not sure yet, what do others think?
The 3 rainmakers for SOG collectively generated 90-93% of the Group's revenue for the past three years. They will collectively own 63.91% of the Group post IPO.
Pros:
1) More diversified rain-makers (1 vs 3)
2) Separation of operational and executive management team.
3) Alignment of interests
Cons:
1) Weaker margins than Talkmed.
2) Short operating history.
The yield will prove to be attractive coupled with the low PE. But as others have mentioned, it will be quite tough to secure it from the Public Offer due to the small float available.
Quite interested to see how sustainable this model (Talkmed, SOG) will be in the coming years.
Nick,
To add on to the discussion on SOG as a long term investment, i believe the key is whether the IPO can act as a catalyst to attract more doctors to join SOG. The monetary incentives of joining SOG suddenly becomes better overnight vs. running your own private practice (i.e. i might be able to get stock options on top of my salary)
If SOG can reduce the concentration risk and diversify its revenue base away from the 3 doctors, then i would start seriously considering it as a long term play. I think for long term investors the 2 things to look out for are: 1) how quickly SOG expands its stable of doctors post IPO 2) Shareholder activity post the 6 month moratorium
In the short to medium term though, as Cityfarmer pointed out i agree that it should trade closer to Talkmed implying a ~50% upside. I don't see how you can lose money on this trade given the solid cashflows, debt-free balance sheet, dividend yield and relatively undemanding valuations. Therefore i will subscribe for this IPO too. All the best to everyone participating!